Why the study?
Does selective administration of prophylactic anticoagulants based on risk profile reduce total mortality in patients following total hip replacement?
Does selective administration of prophylactic anticoagulants based on risk profile reduce total mortality in patients following total hip replacement?
Answers are grounded in this paper and cite their sources.
Risk stratification for postoperative thromboembolism can guide the selective use of prophylactic anticoagulants to balance the risks of fatal pulmonary embolism and bleeding in total hip replacement patients.
Obesity, edema in the legs before surgery, a history of deep venous thrombosis, varicose veins, and a diagnosis of osteoarthrosis were associated with an increased risk for postoperative thromboembolism. Selective administration of anticoagulants to high risk but not to low risk patients should result in a reduction in total mortality following surgery. It is therefore suggested that when deciding whether prophylactic anticoagulants should be administered to a patient, consideration should be given to that patient's likelihood of developing fatal pulmonary embolism if the anticoagulant is not given, compared to the potential reduction in his risk for fatal pulmonary embolism and the increase in risk for fatal bleeding complications if the anticoagulant is used.
No takes yet. Share an insight, caveat, or question.
Kelsey et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: